Candidate plasma biomarkers for predicting ascending aortic aneurysm in bicuspid aortic valve disease.
dc.contributor.author | Harrison, O | |
dc.contributor.author | Cagampang, F | |
dc.contributor.author | Ohri, S | |
dc.contributor.author | Torrens, C | |
dc.contributor.author | Salhiyyah, K | |
dc.contributor.author | Modi, A | |
dc.contributor.author | Moorjani, N | |
dc.contributor.author | Whetton, Anthony D | |
dc.contributor.author | Townsend, Paul A | |
dc.date.accessioned | 2018-07-29T12:45:32Z | |
dc.date.available | 2018-07-29T12:45:32Z | |
dc.date.issued | 2018-06-22 | |
dc.identifier.citation | Candidate plasma biomarkers for predicting ascending aortic aneurysm in bicuspid aortic valve disease. 2018, 13(1): 76 J Cardiothorac Surg | en |
dc.identifier.issn | 1749-8090 | |
dc.identifier.pmid | 29929532 | |
dc.identifier.doi | 10.1186/s13019-018-0762-1 | |
dc.identifier.uri | http://hdl.handle.net/10541/621156 | |
dc.description.abstract | Bicuspid aortic valve (BAV) disease is the most common congenital cardiac abnormality affecting 1-2% of the population and is associated with a significantly increased risk of ascending aortic aneurysm. However, predicting which patients will develop aneurysms remains a challenge. This pilot study aimed to identify candidate plasma biomarkers for monitoring ascending aortic diameter and predicting risk of future aneurysm in BAV patients. | |
dc.language.iso | en | en |
dc.rights | Archived with thanks to Journal of cardiothoracic surgery | en |
dc.title | Candidate plasma biomarkers for predicting ascending aortic aneurysm in bicuspid aortic valve disease. | en |
dc.type | Article | en |
dc.contributor.department | Institute of Developmental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK. | en |
dc.identifier.journal | Journal of Cardiothoracic Surgery | en |
refterms.dateFOA | 2018-12-17T15:29:16Z | |
html.description.abstract | Bicuspid aortic valve (BAV) disease is the most common congenital cardiac abnormality affecting 1-2% of the population and is associated with a significantly increased risk of ascending aortic aneurysm. However, predicting which patients will develop aneurysms remains a challenge. This pilot study aimed to identify candidate plasma biomarkers for monitoring ascending aortic diameter and predicting risk of future aneurysm in BAV patients. |